HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Florian Holsboer Selected Research

R 121919

6/2005Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).
12/2003Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Florian Holsboer Research Topics

Disease

19Mood Disorders (Mood Disorder)
10/2018 - 01/2002
19Mental Disorders (Mental Disorder)
01/2017 - 04/2002
18Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2015 - 07/2008
17Anxiety Disorders (Anxiety Disorder)
01/2021 - 01/2002
14Major Depressive Disorder (Major Depressive Disorders)
12/2017 - 08/2005
10Panic Disorder (Panic Attack)
10/2018 - 01/2002
6Body Weight (Weight, Body)
06/2011 - 11/2003
5Wounds and Injuries (Trauma)
05/2015 - 02/2009
5Schizophrenia (Dementia Praecox)
02/2015 - 08/2005
5Depressive Disorder (Melancholia)
04/2012 - 04/2003
4Weight Gain
01/2019 - 03/2005
4Pituitary Neoplasms (Pituitary Adenoma)
01/2013 - 02/2003
4Neoplasms (Cancer)
01/2013 - 02/2003
4Multiple Sclerosis
11/2009 - 06/2002
4Glucocorticoid Receptor Deficiency
06/2009 - 06/2002
3Cognitive Dysfunction
06/2013 - 05/2006
3Prolactinoma (Prolactinomas)
11/2006 - 02/2003
2Hypersensitivity (Allergy)
06/2014 - 04/2006
2Memory Disorders (Memory Loss)
06/2013 - 05/2006
2Bipolar Disorder (Manic Depressive Psychosis)
08/2012 - 01/2006
2Cushing Syndrome
07/2012 - 09/2005
2Alzheimer Disease (Alzheimer's Disease)
04/2012 - 05/2006
2Shock
02/2012 - 05/2009
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2012 - 04/2005
2Alcoholism (Alcohol Abuse)
08/2009 - 05/2002
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2009 - 10/2004
2Restless Legs Syndrome (Restless Legs)
08/2008 - 02/2008
2Inflammation (Inflammations)
10/2006 - 01/2006
2Neuroblastoma
11/2005 - 10/2003
1Virus Diseases (Viral Diseases)
12/2019
1Obesity
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Personality Disorders (Personality Disorder)
10/2014
1Brain Neoplasms (Brain Tumor)
01/2013
1Glioma (Gliomas)
01/2013

Drug/Important Bio-Agent (IBA)

13Antidepressive Agents (Antidepressants)IBA
01/2019 - 11/2005
13Proteins (Proteins, Gene)FDA Link
02/2015 - 01/2004
13Hormones (Hormone)IBA
07/2014 - 03/2002
11Dexamethasone (Maxidex)FDA LinkGeneric
06/2014 - 01/2002
10Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
07/2014 - 12/2003
10Corticotropin-Releasing HormoneIBA
01/2013 - 01/2004
9Biomarkers (Surrogate Marker)IBA
01/2017 - 04/2005
9Hydrocortisone (Cortisol)FDA LinkGeneric
02/2012 - 11/2003
8Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
06/2014 - 07/2008
8GlucocorticoidsIBA
01/2013 - 06/2002
6Adrenocorticotropic Hormone (ACTH)FDA Link
10/2008 - 03/2002
5Biological ProductsIBA
01/2017 - 10/2010
4Pharmaceutical PreparationsIBA
01/2019 - 09/2007
4NeuropeptidesIBA
01/2015 - 10/2004
4Vasopressins (Vasopressin)IBA
05/2012 - 01/2002
4gamma-Aminobutyric Acid (GABA)IBA
07/2009 - 01/2002
3Messenger RNA (mRNA)IBA
10/2018 - 02/2003
3Purinergic P2X7 ReceptorsIBA
11/2017 - 01/2016
3LigandsIBA
05/2012 - 07/2009
3Sodium LactateFDA LinkGeneric
01/2012 - 03/2002
3CytokinesIBA
02/2010 - 11/2003
3ProlactinIBA
08/2009 - 03/2002
3Estrogen ReceptorsIBA
11/2006 - 02/2003
3Serotonin (5 Hydroxytryptamine)IBA
11/2005 - 12/2002
2Steroid Receptors (Steroid Receptor)IBA
01/2021 - 04/2002
2Mirtazapine (Rexer)FDA LinkGeneric
01/2019 - 02/2009
2Glutamine (L-Glutamine)FDA Link
11/2017 - 01/2016
2Arginine (L-Arginine)FDA Link
11/2017 - 01/2016
2Codon (Codons)IBA
11/2017 - 01/2016
2Tacrolimus Binding Proteins (FKBP)IBA
05/2015 - 12/2012
2Antipsychotic Agents (Antipsychotics)IBA
10/2014 - 11/2005
2Fluoxetine (Prozac)FDA LinkGeneric
01/2013 - 01/2012
2tacrolimus binding protein 5IBA
01/2013 - 11/2011
2Psychotropic Drugs (Psychoactive Drugs)IBA
11/2012 - 03/2005
2TetragastrinIBA
01/2012 - 02/2003
2Lactic Acid (Lactate)FDA LinkGeneric
01/2012 - 03/2002
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2012 - 04/2003
2SteroidsIBA
09/2011 - 01/2002
2Glycogen Synthase Kinase 3 betaIBA
11/2010 - 07/2009
2Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2010 - 08/2005
2ProteomeIBA
11/2009 - 07/2004
2BenzodiazepinesIBA
07/2009 - 10/2004
2Anti-Anxiety Agents (Anxiolytics)IBA
07/2009 - 02/2003
2GalaninIBA
01/2008 - 10/2004
2Paroxetine (Paxil)FDA LinkGeneric
10/2006 - 01/2002
2GadoliniumIBA
05/2006 - 06/2002
2R 121919IBA
06/2005 - 12/2003
2NeurosteroidsIBA
02/2003 - 01/2002
1Beclin-1IBA
12/2019
1CarbohydratesIBA
01/2019
1Glycogen Synthase KinasesIBA
10/2018
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
05/2015
1Synapsins (Synapsin I)IBA
02/2015
1mesoglycanIBA
01/2015
1NectinsIBA
06/2013
1Protein Isoforms (Isoforms)IBA
01/2013
1ChromatinIBA
01/2013
1MicroRNAs (MicroRNA)IBA
01/2013
1Calcium Channels (Calcium Channel)IBA
08/2012
1AnkyrinsIBA
08/2012
1CorticosteroneIBA
07/2012
1NeurotensinIBA
05/2012
1TachykininsIBA
05/2012
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
05/2012

Therapy/Procedure

4Therapeutics
05/2012 - 09/2006